Novavax’s Covid Vax Effective, But Concerns Remain Over Myocarditis Risk: FDA ...Middle East

New York:  The US Food and Drug Administration has called Novavax’s protein-based vaccine effective against Covid-19, but has flagged concerns over its risk of myocarditis and pericarditis. Myocarditis is inflammation of the heart muscle, and pericarditis is inflammation of the outer lining of the heart. In both cases, the body’s immune system causes inflammation in […] The post Novavax’s Covid Vax Effective, But Concerns Remain Over Myocarditis Risk: FDA appeared first on Ommcom News.

Hence then, the article about novavax s covid vax effective but concerns remain over myocarditis risk fda was published today ( Monday 06/06/2022 - 03:28 PM ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax’s Covid Vax Effective, But Concerns Remain Over Myocarditis Risk: FDA )

Also on site :

• ABC Explains 'General 'Hospital' Preemption, Sets New Airdate
• Beloved ‘Beaches’ Star Barbara Hershey, 77, Is a Gray-Haired Beauty on the Red Carpet in Rare Appearance
• Will Trent's Erika Christensen On The Significance Of Angie Having A Girl, Her Engagement To Seth, And What Changes (And Doesn't) With Will